The rapid development of next-generation sequencing (NGS) technologies has allowed researchers to make unprecedented progress in the analysis of genomes, the results of which have profound implications for human health. The ability to fully characterize genomes remains unrealized, however, due in large part to our inability to reconcile sequence information over long distances. Current long-read, long-template, and synthetic library technologies are underpowered, inconvenient, and expensive. They do not provide a high-throughput, single- platform solution for the de novo assembly of complex genomes. RedVault Biosciences is developing an innovative long template NGS technology that could fundamentally advance our current genome analysis strategies and would have broad applications in the clinic and laboratory. Our previous Phase I study (R43 CA196134) demonstrated feasibility and validated the early components of the technology by creating long template dumbbell (LTD) libraries from genomic DNA and analyzing highly-process, strand-displacing DNA polymerases. Solid-phase rolling circle replication (RCR) was performed from 2-kb and 10-kb genomic LTD libraries and bound products were thoroughly characterized. To demonstrate application using current sequencing technology, we propose a second Phase I grant to show feasibility of our LTD approach with a commercial NGS platform. If successful, our overall goal is to fully develop and translate RedVault's LTD sequencing technology into a robust integrated NGS pipeline capable of resolving complex structural variation and improving de novo genome assembly.
Specific Aim 1 will focus on standardizing LTD construction protocols with a commercial, short- read NGS platform.
Specific Aim 2 will demonstrate compatibility of RedVault's LTD RCR products with short-read NGS sequencing chemistry using arrayed flow cells, short-read NGS components and reduced complexity single base extension experiments.
Specific Aim 3 will optimize compatibility and performance by iteratively sequencing and assembling the C. elegans genome from multiple LTD libraries.

Public Health Relevance

The study and sequencing of genomes has led to amazing discoveries in forensics, history, and medicine. Previous methods associated with preparing a DNA sample for sequencing depend on computationally reconstructing small pieces of data to understand genomic structure and variations, which is time intensive, error prone, and not accurate enough for large scale genomic information. The research proposed here is oriented toward significantly improving the methods of sample preparation, which will lead to improved efficiency, accuracy, and reduced costs to sequence DNA, thereby making the technology more accessible to more people.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA232896-01A1
Application #
9680302
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Lou, Xing-Jian
Project Start
2019-02-01
Project End
2021-01-31
Budget Start
2019-02-01
Budget End
2021-01-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Redvault Biosciences, Lp
Department
Type
DUNS #
079101125
City
Houston
State
TX
Country
United States
Zip Code
77027